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Abstract
Plasmacytoid dendritic cells (pDC) are the major source of type I
interferons (IFN-I) during viral infections, in response to triggering
of endosomal Toll-like receptors (TLRs) 7 or 9 by viral single-
stranded RNA or unmethylated CpG DNA, respectively. Synthetic
ligands have been used to disentangle the underlying signaling
pathways. The adaptor protein AP3 is necessary to transport molec-
ular complexes of TLRs, synthetic CpG DNA, and MyD88 into endo-
somal compartments allowing interferon regulatory factor 7 (IRF7)
recruitment whose phosphorylation then initiates IFN-I production.
High basal expression of IRF7 by pDC and its further enhancement
by positive IFN-I feedback signaling appear to be necessary for
robust cytokine production. In contrast, we show here that in vivo
during mouse cytomegalovirus (MCMV) infection pDC produce high
amounts of IFN-I downstream of the TLR9-to-MyD88-to-IRF7
signaling pathway without requiring IFN-I positive feedback, high
IRF7 expression, or AP3-driven endosomal routing of TLRs. Hence,
the current model of the molecular requirements for professional
IFN-I production by pDC, established by using synthetic TLR ligands,
does not strictly apply to a physiological viral infection.
Keywords IRF7; mouse cytomegalovirus; plasmacytoid dendritic cells; type I
interferons; viral infection
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Introduction
Type I and III interferons (IFN-I/III) are cytokines produced early
in vivo during viral infections and playing a major role in host resis-
tance. Both cytokine families induce the expression of numerous
interferon-stimulated genes (ISG) involved in diverse biological
functions, including the direct inhibition of viral replication and the
activation of innate and adaptive immunity (Tomasello et al, 2014).
IFN-I can act on all cell types since their receptor is ubiquitously
expressed, whereas IFN-III selectively targets epithelial cells due to
their selective expression of the receptor for these cytokines.
Upon sensing of viral replication, through triggering of cytosolic
receptors for RNA or DNA, virtually any infected cell type can
produce IFN-I/III. However, many viruses have evolved to interfere
with this detection, expressing genes able to delay, blunt, or prevent
IFN-I/III production by infected cells. As a likely countermeasure to
this immune evasion strategy, vertebrates have evolved professional
IFN-I/III-producing cells, corresponding to specialized mononuclear
phagocytes that are refractory to viral infection, thus escaping cell-
intrinsic effects of viral immunoevasion genes, but that can engulf
and recognize viral material to produce high levels of cytokines
(Tomasello et al, 2014). The first identified professional IFN-I-produ-
cing cells were human plasmacytoid dendritic cells (pDC) (Cella
et al, 1999; Siegal et al, 1999). pDC are well conserved along warm-
blooded vertebrate evolution, based on both their professional IFN-I
production and their global gene expression profile (Asselin-Paturel
et al, 2001; Dalod et al, 2002; Robbins et al, 2008; Vu Manh et al,
2015). Activated pDC also produce IFN-III (Yin et al, 2012) and pro-
inflammatory cytokines and chemokines (Swiecki & Colonna, 2015).
pDC are the major early source of IFN-I/III in vivo during viral
infections, as shown in mice and macaques (Malleret et al, 2008;
Tomasello et al, 2014). In mice, pDC can promote resistance to
systemic acute infection by the herpes simplex virus 2 (HSV-2)
(Swiecki et al, 2013). However, how their professional IFN-I/III
production precisely contributes to this protection remains to be
deciphered. pDC role in shaping antiviral innate and adaptive
immunity might supersede their contribution to the induction of
IFN-I-dependent cell-intrinsic antiviral defenses, as recently
proposed in various mouse models of viral infections (Swiecki et al,
2013; Cocita et al, 2015; Brewitz et al, 2017). During chronic viral
infections in mice, macaques, and humans, pDC production of, and
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response to, IFN-I can play protective or deleterious roles
(Tomasello et al, 2014). The tumor microenvironment inhibits pDC
production of IFN-I/III and polarizes their functions toward
immunosuppression, which can be reversed in mice upon intra-
tumoral administration of oncolytic viruses or synthetic virus-type
stimuli (Fonteneau et al, 2013; Le Mercier et al, 2013). IFN-I
production by pDC contributes to several autoimmune or inflamma-
tory diseases (Tomasello et al, 2014). Hence, understanding the
mechanisms controlling IFN-I/III production specifically in pDC
should help developing innovative treatments against viral infec-
tions, cancer, and autoimmune/inflammatory diseases.
pDC are mainly activated upon triggering of endosomal TLR7
and TLR9 by their respective ligand pairs, uridine-containing
single-stranded RNA and guanosine (Shibata et al, 2016; Zhang
et al, 2016), unmethylated CpG DNA (Kadowaki et al, 2001), and
50-xCx DNA (Ohto et al, 2018). To be active, TLR7/9 need
UNC93B1-dependent routing from ER to dedicated endosomes
where they are cleaved to expose their ligand-binding domain.
Their triggering then initiates a MyD88-to-IRF7 signaling pathway
leading to high-level production of all IFN-I/III subtypes (Honda
et al, 2005a,b; Swiecki & Colonna, 2015). Studies in Irf5-KO mice
suggested that pDC production of pro-inflammatory cytokines is
mainly IRF5-dependent (Takaoka et al, 2005). This differential
involvement of IRF7 versus IRF5 in the production of different
cytokines by mouse pDC has been associated with signaling from
different endosomes (Sasai et al, 2010). The signaling cascade lead-
ing to IFN-I production is proposed to be initiated in dedicated
endosomes to which TLR7/9 are sorted by AP3-dependent mecha-
nisms for pre-association with MyD88 and IRF7. Upon TLR trigger-
ing, this allows fast and efficient activation of IRF7 by the NF-kB
pathway kinases IKKa and IKKb (Hoshino et al, 2006; Pauls et al,
2012; Hayashi et al, 2018). In most cells, IRF7 expression is barely
detectable at steady state, but significantly increased in response to
IFN-I via positive feedback (Marie et al, 1998; Sato et al, 1998).
However, pDC constitutively express high levels of IRF7 which is
commonly accepted as being a key mechanism endowing them
with their professional IFN-I/III production (Kerkmann et al, 2003;
Honda et al, 2005b; Prakash et al, 2005; O’Brien et al, 2011; Kim
et al, 2014; Swiecki & Colonna, 2015). High constitutive IRF7
expression by pDC has been proposed to result from tonic
responses to very low homeostatic IFN-I levels, based on in vitro
experiments (Taniguchi & Takaoka, 2001; Honda et al, 2005b;
Prakash et al, 2005; O’Brien et al, 2011). However, whether in vivo
pDC professional IFN-I production necessitates positive feedback
from these cytokines is controversial. It may depend on the precise
nature of the TLR7/9 ligands used. It is critical when mouse pDC
are stimulated in vivo with synthetic TLR7/9 ligands (Asselin-
Paturel et al, 2005). It might not be necessary in mice infected with
vesicular stomatitis virus (VSV) (Barchet et al, 2002) but appears
to boost systemic IFN-I production during mouse cytomegalovirus
(MCMV) infection (Dalod et al, 2002). IFN-I modulation of their
own production by pDC in vivo has only been investigated in mice
genetically deficient for the expression of the IFN-I receptor (Ifnar1-
KO animals), where the responses of all cells to the cytokines are
abrogated leading to enhanced viral replication and perturbed
immune responses. Hence, further experiments are required to
rigorously investigate whether, and how, cell-intrinsic IFN-I
responses modulate pDC functions in vivo. More generally, because
many studies aiming at deciphering how the production of IFN-I/III
is controlled specifically in pDC have been conducted in vitro or
with synthetic TLR ligands, it is crucial to examine whether the
same mechanisms operate in vivo during a viral infection. To
address these questions, we combined MCMV infection as a physio-
logical model of the interactions between a virus and its natural
host, with gene expression profiling and functional studies on
ex vivo isolated pDC, comparing results between WT and mutant
mixed bone marrow chimera (MBMC) mice. Our results show that
in vivo production of IFN-I by mouse pDC required triggering of the
canonical TLR9-to-MyD88-to-NFKB/IRF7 signaling pathway both
during MCMV infection and upon CpG DNA (CpG) administration,
whereas positive IFN-I feedback signaling and AP3 function were
only essential in response to the later stimulation. Thus, our study
suggests that physiological viral infections likely trigger additional
activation pathways in pDC as compared to stimulation with
synthetic TLR ligands, allowing to bypass some of the molecular
requirements identified in the later stimulation condition.
Results
pDC are activated under combined and distinctive instruction by
TLR, IFN-I, and IFN-c, during MCMV infection in vivo
Intraperitoneal injection of mice with MCMV leads to a rapid and
robust production of IFN-I by splenic pDC, in a TLR7/9- and
MyD88-dependent manner (Dalod et al, 2002, 2003; Krug et al,
2004; Delale et al, 2005; Zucchini et al, 2008a,b). It also induces
pDC phenotypic maturation under IFN-I instruction (Dalod et al,
2003). Hence, we used this model of interaction between a virus
and its natural mammalian host to more broadly investigate the
respective roles of MyD88- and IFN-I-dependent signaling path-
ways in shaping pDC activation under a physiological viral infec-
tion. Because MyD88 and the receptor for IFN-I (IFNAR) are
expressed in many cell types, their genetic inactivation affects
many processes during MCMV infection (Krug et al, 2004; Delale
et al, 2005; Strobl et al, 2005; Baranek et al, 2012; Cocita et al,
2015; Madera & Sun, 2015; Puttur et al, 2016). Thus, to address
the cell-intrinsic role of MyD88- and IFN-I-dependent signaling
pathways in pDC, we generated MBMC mice (Fig 1A). Recipient
CD45.1 mice were lethally irradiated and reconstituted with a 1:1
mixture of bone marrow (BM) cells from WT CD45.1 and Ifnar1-
KO or Myd88-KO CD45.2 donor animals, to generate test mice
(TST MBMC). Congenic CD45.1+ mice differ from the CD45.2+
C57BL/6 strain for several gene polymorphisms and immune
parameters (Waterstrat et al, 2010). Therefore, we included as
controls mice engrafted with a mixture of WT CD45.1 and WT
CD45.2 BM cells (CTR MBMC) (Fig 1A). MBMC were infected with
MCMV at least 8 weeks after BM graft. Splenic pDC, identified as
lineage CD11b CD11clow/int CD317high cells (Figs 1B and EV1),
were isolated 1.5 days after infection, at the peak of IFN-I produc-
tion, sorted into CD45.1+ WT versus CD45.2+ Ifnar1-KO or
Myd88-KO populations (Fig 1B), and used for pangenomic gene
expression profiling by microarrays (Fig 1C–F). Our strategy for
pDC phenotypic identification was validated by two independent
analyses. First, we showed that over 94% of the gated cells
expressed high levels of SiglecH (Fig EV1), another cell surface
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marker selectively expressed on mouse pDC. Second, gene expres-
sion profiling showed that the cell populations sorted as lineage
CD11b CD11clow/int CD317high cells harbored a transcriptional
signature typical of bona fide pDC, likewise to the pDC sorted by
the ImmGen consortium (Fig EV2; Appendix Fig S1). They lacked
any evidence of contamination by other immune cell types,
namely B cells, T cells, NK cells, and other lymphoid cells; cDC1s,
cDC2s, monocytes, macrophages, and other myeloid cells
(Fig EV2; Appendix Fig S1). To ensure that the transcriptomic
responses observed in MBMC pDC were not strongly affected
by BM transplantation, we also sorted splenic pDC from non-
irradiated C57BL/6 animals.
A
C F
D
E
B
Figure 1.
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In hierarchical clustering analysis, Ifnar1-KO pDC isolated from
infected Ifnar1-TST MBMC segregated with the pDC isolated from
uninfected MBMC and C57BL/6 mice (Fig 1C). In contrast, MyD88-
KO pDC isolated from infected Myd88-TST MBMC regrouped with
all the other pDC populations isolated from infected animals in the
second major branch of the tree. Consistently, in principal compo-
nent analysis (PCA), the first axis (PC1) accounting for most of the
variability of the dataset (26%) separated pDC samples according to
the infection status of the mice, except for Ifnar1-KO pDC from
infected MBMC which regrouped with pDC from uninfected animals
(Fig 1D). The second axis (PC2, 17%) separated pDC populations
according to each experiment, with a stronger difference between
the Myd88-KO and Ifnar1-KO MBMC experiments than between the
latter and non-irradiated C57BL/6 animals, consistent with hierar-
chical clustering. Hence, MCMV infection had a strong impact on
pDC transcriptional reprogramming, which was largely unaffected
by the BM engraftment protocol and much more profoundly driven
by IFN-I-dependent signaling pathways than by MyD88.
To precisely identify how MCMV infection affected the gene
expression program of pDC, and the contribution of cell-intrinsic
IFN-I or MyD88 signaling to this response, we identified the genes
that were (i) differentially expressed in WT pDC between uninfected
versus MCMV-infected mice (Fig 1E, gray circle), (ii) expressed to
lower levels in Ifnar1-KO pDC from infected mice as compared to
their WT counterparts (pDC IFN-I-stimulated genes, ISG, Fig 1E, red
circle), or (iii) expressed to lower levels in Myd88-KO pDC from
infected mice as compared to their WT counterparts (pDC MyD88-
stimulated genes, MSG, Fig 1E, green circle) (Table EV1). We gener-
ated a Venn diagram for visual analysis of the relative size of these
three gene lists and of their overlap (Fig 1E). pDC ISG were much
more numerous that pDC MSG. Indeed, 56% of all the DEGs upregu-
lated in pDC during MCMV infection (n = 292) were ISG (n = 164),
whereas only 8% were MSG (n = 23). Apparently, 37% (n = 109)
of these DEGs required neither cell-intrinsic IFN-I nor MyD88 signal-
ing for their induction. Hence, this analysis confirmed that pDC gene
expression reprograming during MCMV infection is much more
profoundly driven by IFN-I-dependent than by MyD88-dependent
signaling. Representative genes were selected to generate a heatmap
illustrating these different expression patterns (Fig 2).
We mined the different gene modules established through the
Venn diagram analysis for enrichment in annotations linked to
specific signaling pathways, biological functions, diseases, or
upstream regulators, using ingenuity pathway analysis (IPA)
(Fig 1F).
Both pDC gene modules (A) and (B) were enriched for IFNB1-,
IRF7-, and IRF3-regulated genes as well as for ISG induced in vivo in
splenic CD11c+ MHC-II+ Flt3+ cells 2 h after subcutaneous IFN-a
administration in mice (“ImmGen DC ISG”) (Mostafavi et al, 2016).
However, only the pDC ISG gene module (A) was significantly
enriched in targets of the canonical transcription factor complex
downstream of IFNAR1 triggering, ISGF3, consistent with the exclu-
sive dependency on cell-intrinsic IFN-I signaling of its induction in
pDC from infected mice, as exemplified by the OAS gene family
(Fig 2). Of note, among the 164 genes whose induction in pDC was
dependent on cell-intrinsic IFN-I signaling (Table EV1), over 50 had
not been identified as ISG in other mononuclear phagocytes or in
lymphocytes (Mostafavi et al, 2016), further emphasizing cell type-
dependency of IFN-I responses. The gene module (B) was more
significantly enriched in IFN-c target genes. In the ImmGen experi-
ment, many genes were induced in DC by subcutaneous injection of
either IFN-I or IFN-c. Since no MBMC experiments were performed,
the apparent redundancy between IFN-I and IFN-c effects on DC
might have been indirect, consecutive to IFN-c induction upon IFN-I
injection, and reciprocally. In our experiments, Irgm1/2 induction in
pDC must have been driven by IFN-c, since their expression was
not affected in Ifnar1-KO pDC (Fig 2) and these genes are consid-
ered to be archetypical IFN-c targets. Unexpectedly, although Cxcl10
is considered to be selectively induced by IFN-I, it belonged to
module (B) suggesting redundancy between IFN-I and IFN-c signal-
ing for its induction in pDC. The expression of certain known IFN-c-
stimulated genes, such as Gbp family members (Fig 2), was higher
in Ifnar1-KO pDC as compared to their WT counterparts, consistent
with the known antagonistic effects of IFN-I signaling on IFN-c
responses. Whereas IPA highlighted MyD88 and IFNAR1 as poten-
tial upstream regulators of both A and D gene modules, our data
show that the former requires IFN-I but not MyD88 cell-intrinsic
signaling for its induction in pDC, and reciprocally for the latter.
Hence, we rigorously determined which gene modules require IFN-I
◀ Figure 1. IFN-I, Myd88, and IFN-c activate distinct sets of genes in mouse pDC during MCMV infection.A Generation of mixed bone marrow chimera (MBMC) mice; CTR, control; TST, test. Recipient CD45.1 (5.1) mice were irradiated and then reconstituted with equal
proportions of bone marrow cells isolated from indicated mice. Mice were used at least 8 weeks after reconstitution.
B Gating strategy. pDC were identified as lineage (TCRb, CD19, Ly6G, NK1.1) CD11b CD11clow/int CD317high cells. 5.2 versus 5.1 cells were finally discriminated within
the pDC gate.
C, D 5.2+ pDC were isolated by sorting from MBMC reconstituted with BM cells from WT B6 (CTR), Ifnar1/-, or Myd88/-deficient (TST) mice. Their 5.1+ WT
counterparts were isolated from the same mice. Two independent experiments were performed for each experimental condition (i.e., with Ifnar1-CTR and –TST
MBMC on the one hand, versus Myd88-CTR and TST MBMC on the other hand). Samples from uninfected animals are shown as empty symbols and those from
MCMV-infected mice as filled symbols. Altogether, this led to 14 biological replicates for WT pDC, irrespective of their CD45 allotypic status and of the type of
MBMC they originated from, both for uninfected and MCMV-infected MBMC. pDC isolated from uninfected or MCMV-infected C57BL/6 mice were included as
internal control. Unsupervised hierarchical clustering (HC) and principal component analysis (PCA) were performed on all the probe sets of the microarrays. For HC,
Pearson correlation distance and Ward’s method linkage were used.
E Venn diagram showing the overlap between the lists of genes significantly upregulated in WT pDC of infected mice (n = 14) as compared to WT pDC of uninfected
animals (n = 14) (gray circle), or downregulated in Ifnar1-KO (n = 2) (red circle) or Myd88-KO (n = 2) (green circle) pDC isolated from infected TST MBMC, as
compared to WT pDC (n = 6) isolated from the same TST or from their matched CTR infected MBMC.
F Enrichment of the gene modules identified in (E) for independent gene sets previously established from the analysis of other microarray datasets (blue font),
belonging to specific signaling pathways (red font), associated with specific functions or diseases (violet font) or regulated by the indicated upstream regulators
(black font), as assessed by using Ingenuity Pathway Analysis (IPA). Data are represented as a heatmap, with gene modules identified in panel (E) as columns and
gene sets as rows. The colored cells indicate the significance of the enrichment of each gene module for each gene set, as computed by IPA analysis and according
to the color scale shown below the heatmap.
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Figure 2. Heatmap showing the expression profiles of selected genes representative of distinct patterns of molecular control in pDC.
Representative genes were selected for modules identified on Venn diagram in Fig 1E and their expression pattern across all samples shown as a heatmap. Red font, pDC ISG
(module A); green font, pDC MSG (module D); mixed red and green font, pDC ISG and MSG (module E); black font, non-ISG and non-MSG (module B). The relative mRNA
expression levels for each gene (lanes) across biological samples (rows) are represented by colors according to the scale shown above the heatmap. For the legend of the
symbols depicting the classes of biological samples above each column please refer to the symbol key in Fig 1D.
ª 2018 The Authors The EMBO Journal 37: e98836 | 2018 5 of 19
Elena Tomasello et al pDC responses to distinct TLR9 ligands The EMBO Journal
versus MyD88 cell-intrinsic signaling for their induction in pDC
during a physiological viral infection in vivo, and delineated non-
redundant versus shared versus antagonistic pDC responses to IFN-I
and IFN-c.
The pDC ISG gene module (A) was the most significantly
enriched in genes upregulated during DC maturation (“DC matura-
tion core up”) (Vu Manh et al, 2013) or associated with annotations
pertaining to antiviral/antibacterial responses or psoriasis. Both
gene modules A and B were highly enriched for genes associated
with insulin-dependent diabetes mellitus or systemic autoimmune
syndrome.
The pDC MSG gene module (D) encompassed mainly genes
encoding cytokines and chemokines, including all the genes for IFN-
I/III (Fig 2), and was enriched for TLR-, MyD88-, CD40-, IRAK3-,
NFKB1-, IKBKB-, IRF1-, IRF3-, IRF7-, and IRF8-regulated genes
(Fig 1F). It was significantly enriched in genes associated with
annotations pertaining to antiviral/antibacterial responses,
inflammation, dendritic cell maturation, and the roles of cytokines
in the communication between immune cells.
Altogether, these results indicate that, in vivo during MCMV
infection, pDC undergo a major transcriptional reprogramming,
under combined instruction of IFN-I, IFN-c, and direct TLR trigger-
ing. However, these different stimuli drive specific, largely distinct,
gene expression programs. In particular, during MCMV infection,
contrary to MyD88 cell-intrinsic signaling, IFN-I responsiveness is
dispensable in pDC for their induction of the expression of many
cytokine genes, including for all IFN-I/III.
IFN-I production by pDC requires neither IFN-I positive feedback
nor AP3-driven TLR endosomal routing during MCMV infection as
opposed to CpG injection
In contrast to what our microarrays showed for pDC transcriptional
responses to MCMV infection, IFN-I positive feedback is necessary
for high-level IFN-I production by pDC upon stimulation by CpG
(Kerkmann et al, 2003; Asselin-Paturel et al, 2005; Kim et al, 2014;
Wu et al, 2016). Hence, we next examined at the single-cell protein
level whether the molecular requirements for in vivo pDC IFN-I
production and phenotypic maturation differed between MCMV
infection and CpG injection. We examined responses 36 h after
MCMV infection versus 7 h after CpG injection, because these time
points correspond to the peak of pDC IFN-I production for these two
stimuli, respectively (Dalod et al, 2002; Krug et al, 2004; Asselin-
Paturel et al, 2005; Zucchini et al, 2008a). MCMV is slowly replicat-
ing, needing 24–30 h to complete its first cycle. Hence, during
MCMV infection in vivo, the peak of pDC IFN-I production occurs 6–
12 h after the release of the first wave of endogenously synthesized
viral CpG DNA sequences, consistent with the kinetics of the
responses to high-dose injection of synthetic CpG. Indeed, reanalysis
of public microarray data showed that all the genes found here to be
significantly modulated in pDC at 36 h after MCMV infection were
similarly modulated upon pDC stimulation with CpG in vitro for 4–
12 h (Appendix Fig S2). We isolated splenic pDC from MCMV-
infected CTR and Ifnar1-KO MBMC and analyzed by flow cytometry
their expression of CD86 and IFN-I. MCMV infection leads to a
decrease in SiglecH expression on pDC (Fig EV1; Puttur et al, 2013).
Moreover, IFN-I production occurred specifically in pDC expressing
higher CD317 but lower SiglecH levels than the bulk of the pDC
population (Fig EV1; Zucchini et al, 2008a). Hence, in order to
ensure the best detection of all IFN-I-producing pDC, we did not add
SiglecH in our pDC gating strategy. Consistent with our microarray
data, during MCMV infection CD86 upregulation but not IFN-I
production was significantly impaired in Ifnar1-KO pDC (Figs 3A–C
and EV1). In contrast, upon in vivo injection of CpG both responses
were abrogated in Ifnar1-KO pDC (Fig 3D). Hence, pDC IFN-I
production does not require IFN-I positive feedback in vivo during
MCMV infection, contrary to CpG injection. IFN-c is one of the
upstream regulators of genes induced in pDC during MCMV infec-
tion, including for the Myd88-dependent gene module encompass-
ing all IFN-I/III genes (Fig 1F). During MCMV infection, IFN-c and
IFN-III are induced to high levels at the same time as IFN-I. Hence,
we wondered whether different IFN types could play redundant
roles in promoting pDC cytokine production during MCMV infec-
tion. Signal transducer and activator of transcription 1 (STAT-1) is a
key element of the signaling cascades downstream of the receptors
to all the three types of IFN. Hence, we compared IFN-I production
in pDC isolated from MCMV-infected CTR versus Stat1-KO MBMC.
No major defect was detected in Stat1-KO pDC (Fig EV3A), thus
excluding a critical contribution of any of the three types of IFN in
promoting IFN-I production by pDC during MCMV infection.
The AP3 adaptor complex is critical for cargo-selective transport
of CpG DNA/TLR/MyD88 complexes to specialized endosomes
where they can recruit IRF7 for IFN-I production (Blasius et al,
2010; Sasai et al, 2010; Prandini et al, 2016). To our knowledge, the
role of AP3 in pDC response to stimulation with viruses was
assessed exclusively in vitro (Blasius et al, 2010; Prandini et al,
2016). Therefore, we compared the cell-intrinsic impact of AP3 loss
on in vivo pDC responses to MCMV infection versus CpG injection
(Fig 3E and F). Neither CD86 upregulation nor IFN-I production was
impaired in Ap3b1-KO pDC during MCMV infection (Fig 3E). In
contrast, during CpG injection, IFN-I production but not CD86
upregulation was significantly decreased in Ap3b1-KO pDC (Fig 3F),
consistent with previous reports (Blasius et al, 2010; Sasai et al,
2010). During MCMV infection, IL-12 production was enhanced in
both Ifnar1-KO and Ap3b1-KO pDC (Fig 3G and H), while slightly
decreased in Stat1-KO pDC (Fig EV3B), consistent with the previous
observations (Dalod et al, 2002; Krug et al, 2004; Sasai et al, 2010).
TNF production was slightly decreased in Ifnar1-KO and in Stat1-KO
but not Ap3b1-KO pDC (Figs 3G and H, and EV3C). Thus, we
showed that AP3 is dispensable for IFN-I production by pDC during
MCMV infection, whereas we confirmed that it is necessary for this
function upon CpG stimulation.
pDC IFN-I production can be promoted via an AP3-independent
but autophagy-related 5 (Atg5)-dependent LC3-associated phagocy-
tosis (LAP) (Henault et al, 2012; Hayashi et al, 2018). Hence, we
investigated whether Atg5 deletion in pDC affected their IFN-I
production during MCMV infection. We generated Siglech-iCre-
knock-in mice in which the improved Cre (iCre) recombinase is
expressed under the control of the Siglech promoter (Fig EV3D).
When Siglech-iCre mice were bred with Rosa26-LSL-RFP mice, RFP
fluorescent protein was expressed in all pDC, thus confirming that
this new mouse model allows selective and efficient gene targeting
in pDC (Fig EV3E). Hence, Atg5 was inactivated in pDC by crossing
Siglech-iCre with Atg5-floxed (fl) mice. Siglech-iCrewt;Atg5fl/fl and
Siglech-iCrehet;Atg5fl/fl mice were used to generate CTR and Atg5fl/fl
MBMC, respectively. Cytokine production and CD86 induction were
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Figure 3. IFN-I-responsiveness and AP3 are dispensable for in vivo IFN-I production in pDC during MCMV infection, but required upon stimulation with CpG.
A Histogram representing CD86 expression in 5.2+ versus 5.1+ pDC isolated from indicated MCMV-infected MBMC; gray, 5.2+ and 5.1+ pDC from CTR MBMC; red, 5.2+
Ifnar1/ pDC isolated from Ifnar1-TST MBMC; purple, 5.1+ WT pDC isolated from Ifnar1-TST MBMC. Dotted line shows isotype control staining. One histogram
representative of six animals from three independent experiments is shown.
B Dot plots represent intracellular IFN-I staining in 5.2+ versus 5.1+ pDC isolated from indicated MCMV-infected MBMC. Isotype control (IC) staining was performed
on a mixture of cells isolated from both types of MCMV-infected MBMC.
C–H The expression of indicated markers was analyzed in 5.2+ versus 5.1+ pDC of each MBMC type. (C–F) Results were expressed as 5.2/5.1 ratio of mean fluorescence
intensity (MFI) values for CD86 or of the percentages of IFN-I-producing cells obtained from MCMV-infected (C, E) or CpG-stimulated (D, F) mice. (G, H) Ratio of IL-
12- and TNF-producing cells in pDC isolated from indicated MCMV-infected MBMC. Black, CTR MBMC; red, Ifnar1-TST MBMC (red); pale blue, Ap3b1-TST MBMC.
Data shown (mean  SEM) are from two pooled independent experiments each with at least three mice per group. ns, not significant (P > 0.05); *P < 0.05;
**P < 0.01; ***P < 0.001; (nonparametric Mann–Whitney test) for panels (C–H).
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not compromised in pDC defective for Atg5 expression (Fig EV3F–
I). Hence, Atg5-dependent LAP is not required for pDC IFN-I produc-
tion during MCMV infection.
In summary, our results show different molecular requirements
for pDC production of IFN-I in vivo during CpG injection versus
MCMV infection, with a strict requirement for IFN-I responsiveness
and AP3 activity only in the former context.
IFN-I production by pDC during MCMV infection requires TLR9-
to-MyD88 signaling, irrespective of their responsiveness to IFN-I
Upon stimulation with synthetic TLR ligand or in vitro exposure to
viruses, IFN-I positive feedback signaling and AP3 activity are
proposed to promote IFN-I production by pDC by enforcing IRF7
activity. They, respectively, amplify its transcription (Kerkmann
et al, 2003; Honda et al, 2005b; Prakash et al, 2005; O’Brien et al,
2011; Kim et al, 2014; Swiecki & Colonna, 2015) or favor its associa-
tion with TLR7/9 and MyD88 in dedicated endosomes (Blasius et al,
2010; Sasai et al, 2010). Hence, the lack of requirement of IFN-I
positive feedback and AP3 activity in pDC for IFN-I production
during MCMV infection calls into question this prevailing model of
the molecular mechanisms controlling IFN-I production by pDC. In
mice infected with the Newcastle disease virus (NDV), loss of IFN-I
responses led to pDC infection and shifted their mechanism of IFN-I
induction from TLR7/MyD88-dependent to viral replication/cytoso-
lic sensor-dependent (Kumagai et al, 2009). Thus, we wondered
whether the differences observed in the molecular requirement for
pDC IFN-I production between MCMV infection and CpG injection
could result from a similar shift in how Ifnar1-KO, Stat1-KO, or
Ap3b1-KO pDC sense MCMV. Indeed, a higher rate of infection of
mutant pDC might allow them compensating impaired TLR7/9-to-
IRF7-to-IFN-I signaling by enhanced triggering of cytosolic sensors
of viral nucleic acids. To assess in vivo the frequency of infected
cells within IFN-producing pDC, we used an MCMV strain engi-
neered to express the fluorescent reporter GFP under control of an
immediate early gene (Henry et al, 2000; Dalod et al, 2003). MCMV
infection was only slightly increased in Ifnar1/ pDC (Fig 4A and
B). Moreover, in both WT and Ifnar1/ pDC, most IFN-I-producing
cells were not infected since they did not express GFP (Fig 4A and
C). Thus, IFN-I production in Ifnar1/ pDC was unlikely to result
from cytosolic virus sensing, at least not from endogenous MCMV
replication. To further confirm that, during MCMV infection, even
in the absence of IFN-I responsiveness, IFN-I production by pDC
was driven by their endosomal recognition of engulfed viral material
through a TLR7/9-to-MyD88-to-IRF7 signaling pathway, we
analyzed infected Myd88-KO and CTR MBMC treated with blocking
anti-IFNAR1 antibodies. In both MBMC types, IFNAR1 blockade
strongly decreased ISG transcription (Fig 4D) and CD86 upregula-
tion (Fig 4E), thus validating treatment efficacy for abrogating IFN-I
responsiveness. If IFNAR1 blockade was shifting the molecular
mechanisms promoting pDC IFN-I production from TLR9/MyD88-
dependent to viral replication/cytosolic sensor-dependent, it would
rescue this function at least partially in Myd88/ pDC. This did not
occur. The production of both IFN-I (Fig 4F) and IL-12 (Fig 4G)
remained defective in Myd88/ pDC despite IFNAR1 blockade.
This was also the case in MCMV-infected Ifnar1-KO × Myd88-KO
mice (Fig 4H–J) and in Tlr9-KO animals (Figs 4K and L, and EV4).
Thus, pDC IFN-I production during MCMV infection strictly requires
TLR9-to-MyD88 signaling and occurs mostly in uninfected cells,
irrespective of their responsiveness to IFN-I.
IRF7 is necessary for IFN-I production by pDC during MCMV
infection, but low levels of this protein are sufficient to promote
this function
In Ifnar1-KO pDC, Irf7 expression was significantly diminished at
steady state and failed to increase upon MCMV infection (Fig 2).
Despite this dramatic reduction in their Irf7 expression, Ifnar1-KO
pDC were not impaired for IFN-I production (Figs 2 and 3B and C).
This suggested that high-level expression of IRF7 is not necessary to
endow pDC with their unique function of professional IFN-I produc-
ers, contrary to current dogma (Kerkmann et al, 2003; Honda et al,
2005b; Prakash et al, 2005; O’Brien et al, 2011; Kim et al, 2014;
Swiecki & Colonna, 2015). However, as IRF7 protein stability can
vary depending on cell activation states (Prakash & Levy, 2006),
mRNA levels might not mirror IRF7 protein quantity. We thus
analyzed IRF7 protein expression in individual pDC by flow cytome-
try. The specificity of the anti-IRF7 mAb used was validated by
using Irf7-KO pDC (Fig 5A, pink and Fig EV5A, left panel). In WT
pDC, IRF7 protein was clearly detectable at steady state (Fig 5A, left
panel, black and Fig EV5A, middle panel) and significantly
increased upon MCMV infection (Fig 5A, right panel and Fig EV5A,
middle panel, black). In WT mice, IRF7 expression was significantly
higher in pDC than in other cells, including conventional DC (cDC)
▸Figure 4. During MCMV infection, the TLR9/Myd88-dependent pathway is necessary for pDC cytokine production, irrespective of their IFN-I responsiveness.A Dot plots represent IFN-I versus GFP staining in 5.2+ versus 5.1+ pDC isolated from indicated MCMV-GFP-infected MBMC. One staining representative of six animals
from two independent experiments is shown.
B, C Percentages of GFP+ cells within 5.2+ pDC (B) or of GFP+ (green) versus GFP (white) cells within 5.2+ IFN-I-producing pDC (C) isolated from indicated MCMV-GFP-
infected MBMC. Data shown (mean  SEM) are from two pooled independent experiments each with three mice per group.
D qPCR for the expression of the indicated genes was performed on whole mRNA isolated from the spleen of indicated MCMV-infected MBMC. CTR MBMC (black)
and Myd88/ TST MBMC (dark green) were treated with isotype control (IC, square) or blocking a-IFNAR1 mAbs (triangle). Data shown (mean  SEM) are from
two pooled independent experiments each with two to three mice per group.
E–G CD86 MFI in 5.2+ pDC of each indicated MBMC type (E) and 5.2/5.1 ratio of cytokine-producing pDC (F, G). Data (mean  SEM) are representative of two pooled
independent experiments each with two to three mice per group.
H–L CD86 MFI (H, K) and percentages of cytokine-producing cells (I, J and L) within pDC of each indicated mouse strain. Black, C57BL6; red, Ifnar1/; orange,
Ifnar1/ × Myd88/; green, Tlr9/; and pale green, Tlr7/. In (K–L), indicated mice were treated with IC (square) or blocking a-IFNAR1 mAbs (triangle). Data
depicted (mean  SEM) are from two pooled independent experiments each with two to three mice per group.
Data information: ns, not significant (P > 0.05); *P < 0.05; **P < 0.01; ***P < 0.001; nonparametric Mann–Whitney test for (B), nonparametric Kruskal–Wallis test
combined with Dunn’s multiple correction test for (D–L).
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and classical monocytes (cMo), although MCMV infection enhanced
expression in all cell types (Fig 5B). In steady-state Ifnar1-KO pDC,
IRF7 was still detectable, but to very low levels as compared to their
WT counterparts (Fig 5A, left panel, red and Fig 5B, left panel,
Fig EV5A, right panel). No increase in IRF7 expression occurred in
Ifnar1-KO pDC upon MCMV infection (Fig 5A, right panel, red and
Fig EV5A, right panel). IRF7 expression was thus very low in
Ifnar1-KO pDC irrespective of MCMV infection and comparable to
that observed in steady-state WT cDC or cMo (Fig 5B). The analysis
of microarray data highlighted IRF1 as a potential upstream regula-
tor of genes induced in pDC upon MCMV infection (Fig 1F). Thus,
in the absence of positive IFN-I feedback loop, decreased pDC
IRF7 activity might be compensated by IRF1 upregulation.
Indeed, IRF1 can drive TLR9/MyD88-dependent IFN-b production
A
B
C D E
Figure 5. IRF7 is necessary for IFN-I production in pDC, but low protein levels are sufficient to promote this function during MCMV infection.
A IRF7 protein expression in pDC isolated from Irf7/ (pink, bottom), C57BL/6 (WT, black, top), and Ifnar1/ (red, middle) uninfected (empty histograms, Ø, left)
versus MCMV-infected mice (filled histograms, MCMV, right). For each condition, histograms are representative of one out of four to six mice from two independent
experiments.
B IRF7 protein expression in pDC (left), cDC (middle), and conventional monocytes (cMo, right) isolated from uninfected (Ø, empty) or MCMV-infected (MCMV, filled)
C57BL/6 (black) or Ifnar1/ (red) mice. Data are shown as net IRF7 MFI, after subtraction of the MFI obtained using isotype control mAbs. Data shown
(mean  SEM) are pooled from two independent experiments with five to six mice for each group.
C–E The expression of CD86 (C) or of indicated cytokines (D, E) was analyzed, as described in Fig 2. Black, CTR MBMC; pink, Irf7-TST MBMC. Mice were treated with
isotype control (IC, square) or blocking a-IFNAR1 mAbs (triangle). Data shown (mean  SEM) are from two pooled independent experiments each with two to
three mice per group.
Data information: ns, not significant (P > 0.05); *P < 0.05; **P < 0.01; ***P < 0.001; nonparametric Kruskal–Wallis test combined with Dunn’s multiple correction test for
(B–E).
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by CpG-B-stimulated monocyte-derived DC and macrophages, inde-
pendently of IRF3 and IRF7 (Schmitz et al, 2007). However, IFNAR1
blockade did not rescue IFN-I production by Irf7-KO pDC during
MCMV infection (Fig 5C and D), showing that IRF1 upregulation
did not functionally compensate IRF7 loss. IL-12 production and
TNF production were not affected in Irf7-KO pDC (Figs 5E and
EV5B), consistent with the specific role of IRF7 in the regulation of
IFN-I production. To more specifically test the role of IRF1, CTR and
Irf1-KO MBMC were infected with MCMV and treated with blocking
a-IFNAR1 antibodies. IFN-I production was not affected in Irf1-KO
pDC, even upon a-IFNAR1 antibody treatment (Fig EV5C). Thus,
low IRF7 expression did not require compensation by IRF1 for IFN-I
production by IFNAR1-unresponsive pDC. IL-12 and TNF-a were
also normal in Irf1-KO pDC and this independently of a-IFNAR1
antibody treatment (Fig EV5D and E). Thus, during MCMV infec-
tion, IRF7 is necessary for IFN-I production by pDC irrespective of
their responsiveness to IFN-I, and very low levels of this transcrip-
tion factor are sufficient to promote this function.
IKKb, but not IKKa kinase activity, is required for IFN-I
production by pDC
Our gene expression profiling of pDC identified the kinase IKKb and
the NF-jB complex among the candidate upstream regulators induc-
ing cytokine transcription in vivo during MCMV infection (Fig 1F).
Both IKKa and IKKb were reported to promote IRF7-dependent IFN-I
production by pDC in response to stimulation with synthetic TLR
ligands (Hoshino et al, 2006; Pauls et al, 2012). Hence, we
compared their role in the promotion of pDC IFN-I production
during MCMV infection or CpG injection. We generated three types
of MBMC: CTR MBMC, IkbkbDItgax TST MBMC in which IKKb is
inactivated in all CD45.2+ CD11c+ cells, including pDC (Baratin
et al, 2015), and IkkaAA TST MBMC where all CD45.2+ cells express
a mutant IKKa bearing alanine substitutions for serines in the kinase
activation loop (Cao et al, 2001). The upregulation of CD86 was
slightly reduced specifically in IkbkbDItgax pDC during MCMV infec-
tion (Fig 6A). IFN-I production was nearly abrogated specifically in
IkbkbDItgax pDC both during MCMV infection (Fig 6A) and CpG
injection (Fig 6B). pDC production of IL-12 and TNF was not
impaired in IkbkbDItgax pDC, while IL-12 produced appeared slightly
enhanced in IkkaAA pDC (Fig 6C). Thus, IKKb, but not IKKa kinase
activity, is critical for IFN-I production by mouse pDC in vivo during
both MCMV infection and CpG injection.
LFA-1 expression on pDC promotes their production of IFN-I
The integrin molecule LFA-1 (alias CD11a) promotes IFN-I produc-
tion by human (Hagberg et al, 2011) and mouse (Saitoh et al, 2017)
pDC activated by immunocomplexes or by synthetic TLR7 ligands,
respectively. Whether this concept can be extended to in vivo antivi-
ral responses has not been yet investigated. Hence, we examined
whether loss of the Itgal gene encoding LFA-1 perturbed pDC activa-
tion in vivo during MCMV infection (Fig 7A) or CpG injection
(Fig 7B). Itgal-KO pDC were not affected in their upregulation of
CD86 but significantly impaired in their production of IFN-I under
both stimuli. During MCMV infection, Itgal-KO pDC were also
impaired for TNF, but not for IL-12 production (Fig EV6A). Hence,
LFA-1 expression on pDC promotes their ability to produce IFN-I
in vivo during MCMV infection or upon CpG injection. This
suggested that pDC IFN-I production may be promoted by the estab-
lishment of LFA1-dependent cell–cell interactions whose precise
nature might differ between viral infection versus synthetic CpG
administration. Although this hypothesis will definitely require dedi-
cated experimental testing, it is consistent with several previously
published reports. First, in vitro, interactions between pDC them-
selves promote their activation in response to CpG stimulation (Kim
A
B
C
Figure 6. IKKb is required for pDC IFN-I production.
A, B Ratio of CD86 expression or IFN-I production in 5.2+ versus 5.1+ pDC
isolated from MCMV-infected (A) or CpG-stimulated (B) MBMC of each
indicated type.
C Ratio of IL-12- or TNF-producing cells in 5.2+ versus 5.1+ pDC of indicated
MCMV-infected MBMC mice.
Data information: Black, CTR MBMC; brown, IkbkbDItgax TST MBMC; pale
brown, IkkaAA TST MBMC. Data shown (mean  SEM) are from two to three
pooled independent experiments each with two to three mice per group. ns,
not significant (P > 0.05); *P < 0.05; **P < 0.01; nonparametric Kruskal–Wallis
test combined with Dunn’s multiple correction test for panels (A–C).
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Figure 7. pDC IFN-I production is promoted by LFA1 engagement and occurs in the vicinity of infected cells during MCMV infection.
A, B Ratio of CD86 expression or IFN-I production in 5.2+ versus 5.1+ pDC isolated from MCMV-infected (A) or CpG-stimulated (B) MBMC of each indicated type. Black,
CTR MBMC; pale pink, Itgal-TST MBMC. Data shown (mean  SEM) are from two pooled independent experiments each with three mice per group. ns, not
significant (P > 0.05); *P < 0.05; **P < 0.01; nonparametric Mann–Whitney test.
C EYFP expression in splenocytes isolated from uninfected (NI) versus MCMV-infected (MCMV) IFNbtm1(EYFP) reporter mice. The expression of indicated markers was
analyzed on YFP+ cells. Plots are representative of one out of six mice from two independent experiments.
D–F Immunohistological analysis of splenic sections stained with mAb against MOMA1/CD169 (blue), GFP/EYFP (green), whose expression correlates with that of IFN-b,
and MCMV IE-1 (red). Scale bars, 100 lm. The image shown is one representative of 15 obtained from five different mice. Optical magnification was 20×, and
images were scanned on the microscope at zoom x2 for (E, F). White dotted lines delimit marginal zone. Yellow squares in (D) defines zoomed region in (E, F).
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et al, 2014; Saitoh et al, 2017). Second, co-culture with infected
cells boosts pDC antiviral responses as compared with exposure to
free virus, mainly in a cell contact-dependent manner (Megjugorac
et al, 2007; Takahashi et al, 2010; Dreux et al, 2012; Decembre
et al, 2014; Frenz et al, 2014; Wieland et al, 2014; Garcia-Nicolas
et al, 2016). Third, pDC IFN-I production during MCMV infection
requires completion of at least one cycle of viral replication and is
more strongly dependent on in vivo viral replication than on the
initial viral inoculum dose, suggesting that pDC recognize MCMV-
infected cells rather than viral particles (Robbins et al, 2007). There-
fore, we sought to investigate whether IFN-I production by pDC
in vivo during MCMV infection occurs in close proximity to infected
cells. We used knocked-in animals expressing the fluorescent
reporter protein EYFP in the 30 UTR of the Ifnb1 gene (Ifnb1EYFP
mice), leading to induction of yellow fluorescence during MCMV
infection mainly in CD11cdim CD317high CD11b Ly6C+ cells corre-
sponding to pDC (Fig 1B; Scheu et al, 2008; Fig 7C). In spleen
sections of MCMV-infected Ifnb1EYFP mice, EYFP+ (IFNb+) cells
were mainly found in the marginal zone, often in close proximity to
MCMV-infected (IE-1+) cells (Figs 7D and EV6B). Despite this co-
localization, we did not detect any double IFNb+ (EYFP+) infected
(IE-1+) cells (Fig 7E and F), consistent with our FACS data showing
that the vast majority of IFN-I-producing pDC are not productively
infected (Fig 4A–C). Some of the infected (IE-1+) cells were also
MOMA-1+ (Fig 7F), indicating that metallophilic marginal zone
macrophages were targets of MCMV infection. Altogether, these
results demonstrate that optimal activation of IFN-I production by
pDC in vivo requires LFA-1 expression and that, during MCMV
infection, IFN-I-producing cells co-localize with MCMV-infected
cells in the marginal zone of the spleen, thus suggesting their poten-
tial interaction in a LFA1-dependent manner.
Discussion
pDC are professional producers of IFN-I/III, able to rapidly produce
very high levels of all these cytokines upon exposure to viruses,
without being themselves infected (Cella et al, 1999; Siegal et al,
1999; Asselin-Paturel et al, 2001; Dalod et al, 2003; Ito et al, 2006;
Zucchini et al, 2008a). Indeed, pDC sense and engulf viral particles
or material from infected cells and route them to dedicated endo-
somes for triggering of a TLR7/9-to-MyD88-to-IRF7 signaling path-
way (Swiecki & Colonna, 2015). Both in human and in mice, other
cell types can sense and engulf viral material. They co-express endo-
somal TLR recognizing these molecules, together with their signal-
ing adaptors. Type 2 cDC and cells of the monocyte/macrophage
lineages express TLR7 or TLR8 with MyD88, and type 1 cDC TLR8/
MyD88 and TLR3/TRIF (Hemont et al, 2013; Dalod et al, 2014).
Type 1 cDC are professional producers of IFN-III but not of IFN-I in
response to TLR3 triggering (Tomasello et al, 2014), whereas unin-
fected type 2 cDC and monocytes/macrophages do not produce high
levels of IFN-I/III upon stimulations with viruses or synthetic TLR
ligands (Diebold et al, 2003; Ito et al, 2006; Zucchini et al, 2008a).
Thus, the professional IFN-I/III production by pDC must result from
molecular and cellular mechanisms selectively present in these cells
and not in cDC or monocytes/macrophages. The currently prevail-
ing model is that pDC functional specialization depends on their
high constitutive IRF7 expression combined with their ability to use
AP3 for sorting TLRs and engulfed material into dedicated endo-
somes (Kerkmann et al, 2003; Honda et al, 2005b; Prakash et al,
2005; Blasius et al, 2010; Sasai et al, 2010; O’Brien et al, 2011; Kim
et al, 2014; Swiecki & Colonna, 2015). However, to our knowledge,
these mechanisms have not been investigated in vivo during a
physiological viral infection.
We compared the cell-intrinsic impact of IFN-I, MyD88, IRF7,
and AP3 activities on pDC IFN-I production in vivo during MCMV
infection versus CpG injection. We confirmed that in both activation
conditions pDC IFN-I production was triggered downstream of a
cell-intrinsic TLR7/9-to-MyD88-to-IRF7/NFKB signaling pathway.
However, AP3 and high-level expression of IRF7 were not necessary
to endow pDC with their professional IFN-I production during
MCMV infection as opposed to CpG administration. Hence, for the
first time to the best of our knowledge, we show that the depen-
dency of in vivo pDC IFN-I production on IFN-I positive feedback
and AP3 activity depends on the stimulus encountered. Further
studies will be necessary to better understand what confers to pDC
their unique ability for rapid and high-level IFN-I production in vivo
during viral infections.
Global gene expression profiling of pDC isolated from MBMC
demonstrated a much broader impact of cell-intrinsic IFN-I
responses than of MyD88 signaling on the transcriptional repro-
gramming of pDC during MCMV infection. Whereas cytokine
production is preserved in pDC lacking IFN-I responsiveness, these
cells fail to upregulate molecules involved in the cross-talk with T
lymphocytes and must more generally be strongly affected for other
processes. Hence, even though loss of IFN-I responsiveness by pDC
during MCMV infection does not compromise their cytokine produc-
tion, it is likely to affect their contribution to the orchestration of
innate and adaptive immune responses, as previously shown for
cDCs (Baranek et al, 2012). Studies addressing this issue are beyond
the scope of the current study and will be pursued independently.
In our experimental settings, IKKa kinase activity is dispensable
for pDC IFN-I production. This seems contradictory with the major
defect of IFN-I production reported in mouse or human pDC lacking
IKKa (Hoshino et al, 2006; Pauls et al, 2012). However, explana-
tions can be proposed to reconcile these observations. Indeed, here
we did not use Ikka/ animals, but a IkkaA/A knock-in mouse
strain expressing a mutated protein devoid of kinase activity (Cao
et al, 2001). Hence, for pDC IFN-I production, IKKa might mostly
function as a docking partner within the IKKa/IKKb/NEMO complex
and not as a kinase. Hence, loss of IKKa might impact pDC IFN-I
production indirectly, by affecting the availability, stoichiometry,
and function of the other molecules composing the complex, includ-
ing IKKb. Indeed, we showed that IKKb deficiency in pDC mainly
impaired IFN-I production without affecting the secretion of other
pro-inflammatory cytokines, such as IL-12 and TNF, thus reproduc-
ing results obtained by using mouse Ikka/ pDC (Hoshino et al,
2006). Alternatively, both IKKa and IKKb could directly signal to
promote IRF7-dependent IFN-I production in pDC, but by using
distinct and complementary mechanisms not requiring Ikka canoni-
cal kinase activity (Pauls et al, 2012).
The lack of AP3 requirement for pDC IFN-I production during
MCMV infection is consistent with the normal levels of circulating
IFN-I in the sera of MCMV-infected Ap3b1/ mice (Del Prete et al,
2015). However, our conclusions drastically differ from those of that
previous report. In that study, pDC from Ap3b1/ mice showed an
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impaired IFN-a and TNF production in vitro in response to free RNA
and DNA viruses, including MCMV. Based on this observation, the
authors inferred that pDC were unable to produce high levels of
IFN-I in MCMV-infected Ap3b1/ mice but that this did not lead to
a decrease in the peak serum levels of these cytokines. Thus, with-
out measuring cytokine production in pDC in vivo, they concluded
that pDC are dispensable for high systemic IFN-I production during
MCMV infection (Del Prete et al, 2015), which is in contradiction
with previous reports (Dalod et al, 2002, 2003; Krug et al, 2004;
Swiecki et al, 2010; Cocita et al, 2015). Here, we showed that
Ap3b1/ pDC mount normal cytokine responses in vivo during
MCMV infection. Altogether, these results show that the molecular
requirements for pDC IFN-I production upon stimulation with
viruses differ between artificial in vitro settings and a physiological
infection in vivo. Hence, caution must be exerted for extrapolation
to in vivo conditions of molecular mechanisms described to control
pDC activation in vitro.
An outstanding question opened by our study is how MCMV
infection allows pDC IFN-I production in vivo to overcome the need
for IFN-I positive feedback and for AP3 that is required for
responses to CpG. We confirmed that cell-intrinsic TLR9 signaling is
critical for promoting pDC cytokine production during MCMV infec-
tion, independently of IFN-I responsiveness. However, we speculate
that MCMV infection delivers additional signals to pDC, overlapping
with IFN-I positive feedback or bypassing AP3 function. Since Stat1-
KO pDC were not affected for IFN-I production during MCMV infec-
tion, we can rule out a redundancy between different IFN types as
the mechanism underlying independency of pDC activation from
IFN-I responsiveness during MCMV infection. We also ruled out
triggering of LC3- and Atg5-dependent phagocytosis (LAP) in pDC
as the mechanism underlying their lack of AP3 requirement for
IFN-I production during MCMV infection. TLR7 and TLR9 can exert
overlapping functions during MCMV infection (Zucchini et al,
2008b). If this cooperation can override the need for IFN-I positive
feedback, we would expect a strong impairment of pDC IFN-I
production in TLR7-KO mice treated with a-IFNAR1 antibodies,
which is not the case. However, we cannot exclude the involvement
of other TLR or pathogen sensors.
Exposure of splenocytes to viruses significantly increases the
stability of IRF7 protein, at least in part through STAT-1-indepen-
dent mechanisms (Prakash & Levy, 2006), consistent with our
observation that IFN-I production by Stat1-KO pDC is not affected
during MCMV infection. Hence, differences in the signals received
by pDC upon different contexts might lead to differential stability
and/or nuclear translocation efficacy of IRF7, explaining the require-
ments for different absolute levels of IRF7. In any case, how pDC
can capture and sense viruses without being infected themselves
remains one of the most puzzling question regarding the biology of
these cells, because the exact nature of the viral material engulfed
by pDC and the endocytic receptors used for this process are still
unknown (Puttur et al, 2013; Alexandre et al, 2014). Physical prox-
imity and eventually cell contact-dependent interaction with virally
infected cells are necessary to promote maximal IFN-I production
in vitro (Takahashi et al, 2010; Decembre et al, 2014; Wieland et al,
2014; Garcia-Nicolas et al, 2016). This interaction allows transfer of
viral material to pDC (Dreux et al, 2012; Wieland et al, 2014).
However, whether similar contacts are required in vivo is unknown
and the underlying molecular mechanisms remain a mystery. Our
data suggest that, during MCMV infection, in the marginal zone of
the spleen, pDC might interact with infected cells through LFA1-
dependent contacts which would promote their IFN-I production.
Additional studies will be required to rigorously test this hypothesis
and to further decipher the nature of the signals delivered by
infected cells, including how they might compensate the loss of
IFNAR1 and AP3 functions for promoting pDC IFN-I production.
However, these studies are currently hampered by the lack of proper
mutant mouse models to specifically track and genetically manipu-
late pDC in vivo. This difficulty stems from the fact that no cell
surface marker, and not even a single gene, has been found to be
specifically expressed on mouse pDC. This includes CD317, which is
induced on other cell types in response to IFN-I, although, on other
CD11c-expressing cells, to lower levels than those observed on pDC,
as well as SiglecH which is also expressed on DC progenitors and on
specific subsets of macrophages (Swiecki et al, 2014; Schlitzer et al,
2015). Consequently, only complex strategies relying on the use of
several positive and negative markers allow unequivocal phenotypic
identification of bona fide pDC, as performed here for flow cytome-
try by defining them as lineage CD11b CD11clow/int CD317high
cells. However, similar types of logic gating strategies are much
more difficult to apply for immunohistofluorescence studies and for
the engineering of mutant mice. Several teams are currently putting
a major effort to overcome this roadblock; once it is achieved, our
understanding of pDC functions and of their molecular regulation
under physiological conditions should advance tremendously.
Materials and Methods
Mice
C57BL/6 mice were purchased from Janvier, France. Congenic
CD45.1 C57BL/6 mice were purchased from Charles River, Italy. All
other mouse strains were bred under specific pathogen-free condi-
tions at the Centre d’ImmunoPhe´nomique (CIPHE) or the Centre
d’Immunologie de Marseille-Luminy, Marseille, France. Ap3b1-KO
(B6Pin.C3-Ap3b1pe/J), IFNbEYFP (B6.129-Ifnb1tm1Lky) reporter mice
and Itgal-KO (B6.129S7-Itgaltm1Bll) mice were purchased from Jack-
son Laboratories, USA. Ifnar1-KO (B6.129S2-Ifnar1tm1agt), Myd88-
KO (B6.129P2-Myd88tm1Aki), Tlr9-KO (129P2-Tlr9tm1Aki), Tlr7-KO
(B6.129P2-Tlr7tm1Aki), Irf7-KO (B6.129P2-Irf7tm1Ttg) (Honda et al,
2005b), IkkaA/A (B6.129P2-Chuktm2Mka) (Cao et al, 2001), Ikbkb-
DItgax (Baratin et al, 2015), and Atg5fl/fl (B6.129S-Atg5tm1Myok)
(Hara et al, 2006; Terawaki et al, 2015) mice were backcrossed on
C57BL/6 background for over eight generations. Rosa26-LoxP_STO-
P_LoxP(LSL)-Red Fluorescent protein, Rosa26-LSL-RFP (B6-Gt
(ROSA)26Sortm1Hjf) mice (Luche et al, 2007) were kindly provided
by B. Malissen (CIML). Ifnar1-KO × Myd88-KO mice were generated
by interbreeding single knock-out mice. Stat1-KO (B6-Stat1tm1d
(EUCOMM)Ciphe), Irf1-KO (B6-Irf1tm1a(EUCOMM)Wtsi), and Siglech-iCre
(B6-Siglechtm1(iCre)Ciphe) mice were generated at CIPHE, Marseille,
France. All animals used were sex- and age-matched. The animal
care and use protocols were designed in accordance with national
and international laws for laboratory animal welfare and experimen-
tation (EEC Council Directive 2010/63/EU, September 2010). They
were approved by the Marseille Ethical Committee for Animal
Experimentation (registered by the Comite´ National de Re´flexion
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Ethique sur l’Expe´rimentation Animale under no. 14; authorization
#11–09/09/2011 and APAFIS#1212-2015072117438525 v5).
Viruses and viral titers
Virus stocks were prepared from salivary gland extracts of 3-week-
old MCMV-infected BALB/c mice. Mice were infected i.p. with
1 × 105 pfu Smith MCMV or 5 × 104 pfu MCMV-GFP (Henry et al,
2000) and sacrificed 36 h after infection. Viral titers were measured
by real-time quantitative RT–PCR as absolute levels of expression of
the Ie1 gene as described (Baranek et al, 2012).
In vivo treatment with synthetic TLR ligands or with
blocking antibodies
Mice were injected i.v. with 10 lg/mouse of the synthetic TLR9
ligand CpGA 2216 (Invivogen, France), complexed with DOTAP
liposomal transfection reagent (Roche Applied Sciences, France),
and sacrificed 7 h after injection. To block IFNAR1, mice were
treated 24 h before sacrifice with 1 mg of isotype control or anti-
IFNAR1 MAR-1 mAbs (BioXcell, USA).
Generation of MBMC
Congenic CD45.1 mice were 8 Gy irradiated, and then reconstituted
with equal proportions of BM cells derived from CD45.1 animals and
from CD45.2 mice either wild type (WT) or deficient for indicated
genes. Mice were used at least 8 weeks after BM reconstitution.
Cell preparation, flow cytometry analysis, and cell sorting
Spleen was harvested and submitted to enzymatic digestion for
25 min at 37°C with collagenase IV (Worthington biochemicals),
DNAse (Roche Diagnostics), and Brefeldin A (Sigma-Aldrich). Red
blood cells were then lysed by using RBC lysis buffer (Affymetrix
eBiosciences, France), and pDC were enriched with the mouse plas-
macytoid dendritic cell isolation kit (Miltenyi Biotec, France). Cell
suspensions were incubated with 2.4G2 (anti-CD16/CD32) mAbs for
10 min, and then, extracellular staining was performed at 4°C in
1× PBS supplemented with 2 mM EDTA (Sigma-Aldrich) and 0.5%
bovine serum albumin (BSA, H2B, Limoges, France). Intracellular
staining was performed after fixation with Cytofix/Cytoperm (BD
Biosciences), by incubation with specific anti-cytokine mAbs diluted
in PermWash (BD Biosciences). mAbs recognizing mouse CD3e
(2C11), CD19 (1D3), Ly6G (1A8), NK1.1 (PK136), CD11b (M1/70),
CD11c (HL3), CD86 (GL3), TNF (MP6-XT22), and IL-12 (C15-6), as
well as their respective isotype controls, were purchased from BD
Biosciences. Purified anti-mouse IFNa (RMMA1) and IFNb
(RMMB1) were purchased from PBL Interferon Source (Tebu,
France); purified rat IgG was used as isotype control (Jackson
Immuno Research); these mAbs were coupled to Alexa647 by using
a monoclonal labeling kit (Southern Biotech, France). Anti-mouse
Bst2/CD317/PDCA1 (eBio927), Irf7 (MNGPKL), and its isotype
control were purchased from Affymetrix eBiosciences, France. Irf7
intracellular staining was performed by using a FoxP3 staining kit
(Affymetrix eBiosciences, France). Samples were acquired on a
FACS LSR II (BD Biosciences, France) and analyzed with FlowJo
software (FlowJo, LLC, USA). For microarray studies, pDC were
sorted to high purity by flow cytometry on a FACS Aria II cell sorter
(BD Biosciences, France) and directly collected in RLT buffer (Qia-
gen, France) supplemented with 10% b-mercaptoethanol.
Immunohistological analysis
Spleen fragments isolated from uninfected or MCMV-infected IFNbEYFP
reporter mice were fixed for 2 h with Antigenfix (DiaPath), then
washed in phosphate buffer (PB1X: 0.025 M NaH2PO4 and 0.1 M
Na2HPO4) for 1 h, dehydrated in 30% sucrose overnight at 4°C, and
embedded in OCT freezing media (Sakura Finetek). Eight-micrometer-
thick tissue sections were blocked in PB1X containing 0.1% saponin,
2% BSA, 2% 2.4G2 supernatant, and streptavidin/biotin blocking kit
(Vector Laboratories) and stained in PB1X with the following antibod-
ies: Alexa488-conjugated rabbit anti-GFP (Invitrogen), mouse Croma
anti-MCMV IE-1 mAb, followed by Alexa633-conjugated goat anti-
mouse IgG2a mAb (Molecular Probes) and biotin rat anti-mouse
CD169 (MOMA1, Abcam), followed by Alexa546-conjugated strepta-
vidin (Thermo Fisher). Stained sections were mounted in ProLong
Gold Antifade reagent (Invitrogen), acquired on a ZEISS LSM780
confocal microscope (Zeiss), and analyzed with ImageJ software.
Microarray data generation and analysis
Independent duplicate samples were generated by using pooled
spleens of uninfected or MCMV-infected indicated mice. Total RNA
was prepared and converted to biotinylated double-strand cDNA
targets which were hybridized on GeneChip Mouse Gene 1.0 ST
arrays (Affymetrix) that were scanned to extract raw data (.CEL
Intensity files) and perform microarray bioinformatics analyses, as
previously described (Baranek et al, 2012; Tamoutounour et al,
2013) and specified in Figure legends. List of genes showing dif-
ferential expression between two different conditions were gener-
ated by statistical analysis using Limma. All WT pDC samples from
infected mice were compared with those from uninfected animals
(n = 14 in each group). Duplicates from Ifnar1-KO or Myd88-KO
pDC from infected MBMC were compared with WT pDC from the
same experiment (n = 2 for mutant pDC and n = 6 for WT control
pDC). Heatmaps were performed using Gene-E (http://www.
broadinstitute.org/cancer/software/GENE-E/). The microarray data
have been deposited in the GEO database (http://www.ncbi.nlm.
nih.gov/geo/) under the series accession number GEO: GSE115450.
qPCR
Total mRNA was converted into cDNA by using QuantiTect Reverse
Transcription kit (Qiagen). qPCR was performed by using a Sybr-
Green kit (Takara) and run on a 7500 Real Time PCR System appa-
ratus (Applied Biosystems). We performed two independent
replicates for each indicated condition by using 2 ng of cDNA/
sample. Relative gene expression was calculated with the DDCt
method using Hprt as housekeeping gene for normalization. Primers
used were the following: Hprt Forward 50-GGCCCTCTGTGTGCTC
AAG-30; Hprt Reverse 50-CTGATAAAATCTACAGTCATAGGAATGG
A-30; Irf7 Forward 50-TCCAGTTGATCCGCATAAGGT-30; Irf7 Reverse
50-CTTCCCTATTTTCCGTGGCTG-30; Isg15 Forward 50-GGTGTCCG
TGACTAACTCCAT-30; Isg15 Reverse 50-TGGAAAGGGTAAGACCG
TCCT-30.
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Statistical analyses
Statistical analyses were performed using a nonparametric Mann–
Whitney test for comparisons between two groups. For comparisons
among three or more groups, we used a nonparametric Kruskal–
Wallis test combined with Dunn’s multiple correction test. All the
analyses were performed with GraphPad Prism 6 software. ns, not
significant (P > 0.05); *P < 0.05; **P < 0.01; ***P < 0.001;
****P < 0.0001. Mean values are indicated as horizontal black bars.
Expanded View for this article is available online.
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